Drugs with this side effect
- 5-ASA: postmarketing, 1% - 28%
- 5-aza-2'-deoxycytidine: 1.23% - 4.82%
- 5-azacytidine: common, 1.09% - 10.9%
- 8-MOP
- AMD3100: common
- CGP 19835A: very common, 13%
- Cancidas: 0% - 5.6%
- EACA
- EDTA
- FAMP: 6% - 8%
- FdUrd
- Fe(III
- Gd-EOB-DTPA
- Ge-132: 5%
- Goserelin: 2% - 5%
- Histrelin
- K779: postmarketing, 3% - 14%
- L-Dmp: infrequent
- Leuprorelin
- Lisinopril: 0.3% - 1.1%
- Lovaza
- Lutalyse
- Mersyndol
- Metrodin: 2.41%
- NuvaRing
- Octreotide
- Optison
- Org 37462: uncommon
- Photofrin II: uncommon
- SU5416
- Sativex
- Stalevo 50
- Supremon
- Triptorelin
- UDCA: postmarketing
- abacavir: 0.971% - 33.7%
- abacavir-lamivudine: common
- acamprosate: infrequent
- acebutolol
- acetaminophen
- acetazolamide
- acetohydroxamic acid
- acipimox
- acitretin: postmarketing
- actinomycin D
- acyclovir: 11.1% - 11.5%
- alendronate: postmarketing
- alfuzosin: 1.4%
- allopurinol: postmarketing
- almotriptan: postmarketing
- alosetron: infrequent
- alprazolam: frequent
- amifostine
- amiodarone
- amitriptyline
- amlodipine
- amlodipine besylate
- amphotericin B
- anagrelide: 6% - 6.4%
- anastrozole
- anthracycline: 1% - 11%
- apraclonidine: postmarketing
- aprepitant
- aripiprazole
- articaine
- atazanavir: uncommon
- atenolol
- atorvastatin
- azathioprine
- azelastine
- azithromycin: postmarketing, 0% - 1.1%
- aztreonam
- baclofen
- balsalazide
- bendamustine
- betahistine: rare
- betaxolol
- bethanechol: postmarketing
- bexarotene
- bile salt
- bisoprolol
- bleomycin hydrochloride
- boceprevir: common
- bortezomib
- bosutinib
- brinzolamide
- bromcresol green
- budesonide
- buprenorphine
- bupropion: postmarketing, rare
- buspirone: infrequent
- cabazitaxel
- cabergoline: 0% - 0.905%
- capecitabine
- captopril
- carbidopa
- carbimazole
- carboplatin
- carvedilol: 1.3%
- cefaclor
- cefotaxime: postmarketing
- cefpodoxime
- ceftriaxone
- cerivastatin
- cetirizine: postmarketing
- cevimeline
- chlorzoxazone
- cidofovir
- cilazapril
- cilostazol
- ciprofloxacin: postmarketing, uncommon
- cisplatin
- citalopram: postmarketing, infrequent, uncommon
- cladribine: common, 5% - 7%
- clarithromycin
- clomipramine: infrequent
- clonazepam
- clonidine
- clozapine
- codeine
- copolymer 1
- cortisol
- cortisone
- cosyntropin
- cyclobenzaprine
- cyclophosphamide: postmarketing
- cyproterone acetate
- cytarabine
- dacarbazine
- dantrolene
- darunavir
- dasatinib: uncommon
- degarelix
- delamanid
- delavirdine
- delta 9-THC: postmarketing
- demethyl
- deprenyl: rare, 0%
- desflurane: postmarketing
- desipramine
- desmopressin
- dexamethasone
- dexamethasone sodium phosphate
- dexrazoxane: 48% - 62%
- diazoxide
- diclofenac
- dicloxacillin
- dicyclomine: postmarketing
- diethylpropion
- dihydroergotamine: infrequent
- diltiazem: postmarketing
- dipyridamole: 0.3%
- disopyramide
- dolasetron
- donepezil: infrequent
- doxazosin: postmarketing, 12% - 14.8%
- doxepin
- doxercalciferol: 27.9%
- doxorubicin: postmarketing, common, 0.4% - 4.8%
- doxycycline
- duloxetine: postmarketing, infrequent, uncommon
- efavirenz
- eletriptan: infrequent
- entacapone
- eplerenone: uncommon
- eprosartan
- ertapenem
- eslicarbazepine acetate
- esomeprazole magnesium
- estazolam: 5%
- estradiol: postmarketing
- ethacrynic acid
- ethambutol
- etodolac
- etoposide: 39%
- etoposide phosphate
- etravirine
- everolimus: 0.5% - 45%
- ezetimibe
- felbamate: frequent
- fenofibrate: 1.5%
- fenoprofen
- fentanyl: 1% - 4%
- flecainide
- flucloxacillin
- fluconazole: postmarketing, uncommon
- fludarabine: 6% - 8%
- flumazenil
- flunisolide
- flunitrazepam: uncommon
- fluorescein: postmarketing
- fluoxetine: infrequent
- flurbiprofen
- flutamide
- fluticasone
- fluticasone propionate: 1% - 4.9%
- fluvastatin: postmarketing
- fluvoxamine: infrequent, common, frequent
- folate
- formoterol
- fosaprepitant
- fosaprepitant dimeglumine
- foscarnet
- fosinopril: uncommon
- fosphenytoin: infrequent
- frovatriptan: infrequent
- gabapentin: infrequent, frequent
- gadobenate dimeglumine
- gadodiamide
- gadolinium: postmarketing
- gadoteridol: postmarketing
- gadoversetamide
- galantamine: frequent, 1.4%
- ganciclovir: 0.8%
- gemcitabine: 19%
- gliclazide
- glipizide
- glutamine: 0% - 12.5%
- granisetron
- guanfacine: postmarketing
- halofantrine
- hepatitis B vaccines: common
- histamine
- hydralazine: uncommon
- hydrochlorothiazide
- hydromorphone
- hydroxocobalamin
- hydroxyurea
- ibandronate
- ibuprofen
- icodextrin: postmarketing
- ifosfamide: 1%
- imatinib: uncommon, 11.7% - 74.9%
- imipramine
- imiquimod: uncommon, 0.2%
- indapamide
- indinavir: 0.5% - 2.1%
- indomethacin
- iodixanol
- iopamidol
- iopromide: postmarketing
- irbesartan: uncommon
- irbesartan-hydrochlorothiazide
- irinotecan
- iron sucrose
- isomannide
- isoniazid
- isosorbide-5-mononitrate
- isradipine
- itraconazole: 1%
- ivabradine
- ketoconazole
- ketoprofen
- ketorolac
- ketorolac tromethamine
- labetalol: 13.1%
- lamivudine: common, 3.66% - 26%
- lamotrigine: infrequent, 2% - 4.9%
- lanreotide
- lansoprazole
- leflunomide
- lenalidomide
- lercanidipine
- letrozole: 0.151% - 10.2%
- leucovorin: 2% - 13%
- leuprorelin acetate
- levodopa/carbidopa
- liraglutide: postmarketing
- lomefloxacin
- lomitapide
- loratadine
- losartan: postmarketing
- lovastatin: postmarketing
- lubiprostone: postmarketing
- mannitol
- mebeverine
- meclofenamate: postmarketing
- medroxyprogesterone acetate
- mefenamic acid
- mefloquine: postmarketing
- megestrol
- megestrol acetate
- meloxicam
- memantine: postmarketing
- mesna: postmarketing
- metformin
- methazolamide
- methotrexate: 1-10%
- methylphenidate
- methylprednisolone
- methysergide
- metolazone: 4.4%
- mexiletine
- miconazole
- mifepristone
- miglustat: common
- minocycline: 3.86%
- mipomersen
- mirtazapine: frequent
- mitomycin C
- mitoxantrone
- moclobemide
- modafinil: postmarketing
- moexiprilat
- morphine: postmarketing
- moxifloxacin
- mycophenolate mofetil
- mycophenolic acid
- nabilone
- nabumetone: 0.8%
- nafcillin
- nalmefene
- naltrexone: postmarketing
- naproxen: postmarketing
- naratriptan: 2%
- nefazodone: infrequent
- nelfinavir
- nevirapine: postmarketing
- nicardipine
- nicorandil: uncommon
- nicotine
- nifedipine
- nilotinib: uncommon, common
- nilutamide: 2%
- nisoldipine
- nitazoxanide
- nitrofurantoin
- nortriptyline
- ofloxacin
- olanzapine: infrequent
- olmesartan: postmarketing
- olopatadine: postmarketing
- omeprazole: postmarketing, uncommon
- ondansetron: 2.29% - 13.2%
- orlistat
- oxacillin
- oxaprozin
- oxcarbazepine
- oxybutynin
- oxycodone
- paclitaxel: postmarketing, rare, very common
- paliperidone
- pamidronate: very common, 0% - 5.8%
- pantoprazole: postmarketing
- papaverine
- paricalcitol: 3.2%
- paroxetine: postmarketing, infrequent, common, frequent, 4.88%
- penicillin
- pentosan polysulfate
- pentoxifylline
- pergolide: infrequent
- perindopril
- perindopril erbumine
- phenelzine
- phenytoin: infrequent
- pioglitazone: 2.8%
- piroxicam
- pitavastatin: postmarketing
- posaconazole
- pramipexole: 2% - 3%
- pravastatin: postmarketing
- praziquantel
- prazosin
- prednisolone
- prednisolone acetate
- prednisolone phosphate
- prednisone
- pregabalin: postmarketing, infrequent
- procainamide
- progesterone: postmarketing
- propafenone
- protriptyline
- prucalopride: uncommon
- pyrazinamide
- quetiapine: infrequent
- quinapril
- quinaprilat
- rabeprazole
- raltegravir
- raltitrexed: 2%
- ramipril
- ramiprilat
- ranitidine
- rapamycin
- rasagiline: common, 2%
- reboxetine
- regadenoson: common
- retigabine
- retinoic acid: postmarketing, 66%
- ribavirin: common, very common, 1% - 6%
- rifapentine
- rifaximin
- riluzole: 0.4% - 1.2%
- risperidone: infrequent
- ritonavir: 0.7% - 5.2%
- rivaroxaban
- rivastigmine: uncommon, common, 4% - 5%
- roflumilast
- ropinirole: infrequent, 3%
- ropivacaine
- rotigotine
- roxithromycin
- salbutamol: postmarketing, 0% - 1.5%
- salmeterol
- saquinavir: common
- sertraline: postmarketing, infrequent, common, frequent, 1% - 10%
- sibutramine
- sildenafil
- simvastatin: postmarketing
- sitagliptin
- sitaxsentan
- sodium cromoglycate
- sodium ferric gluconate
- sparfloxacin
- spironolactone
- strontium ranelate: postmarketing
- sulindac
- sumatriptan: 2% - 9.5%
- tacrolimus
- tamsulosin: 0.4%
- technetium-99m
- telavancin: uncommon
- telmisartan
- temozolomide: common, 2%
- terazosin
- terbinafine: postmarketing
- terconazole: postmarketing
- testolactone
- testosterone: postmarketing
- testosterone enanthate: postmarketing
- testosterone propionate
- testosterone undecanoate
- thalidomide: 0% - 8.33%
- thymidine: 1% - 12%
- tiagabine: frequent
- tigecycline
- tinidazole: 1.1% - 2.1%
- tipranavir: uncommon
- tizanidine: infrequent
- tobramycin: 6.2%
- tolazamide
- tolcapone: 1%
- tolvaptan: common
- topiramate
- topotecan: common, 0.3% - 5%
- tramadol: postmarketing, uncommon
- trandolapril: 0.5% - 1.1%
- trandolaprilat: postmarketing
- tranexamic acid
- trans 4-cyclohexyl-L-proline
- travoprost: uncommon
- trazodone: 0% - 2.8%
- treprostinil
- triamcinolone
- triamcinolone acetonide
- triazolam
- trien
- trimethadione
- trimipramine
- troglitazone: postmarketing
- trovafloxacin
- v 1784: postmarketing
- valdecoxib
- valganciclovir
- valproate
- valrubicin
- vardenafil
- varenicline: uncommon, 4% - 7%
- venlafaxine: infrequent
- vernakalant
- verteporfin
- vigabatrin: 0% - 5%
- vinblastine
- vinflunine
- vinorelbine: 0% - 49%
- voriconazole
- warfarin
- zafirlukast
- zalcitabine
- zaleplon: uncommon, 1% - 2%
- zanamivir: 5% - 8%
- zidovudine: common, 8% - 55.6%
- zidovudine/lamivudine
- zileuton
- zoledronic acid: postmarketing, common, 0.7% - 7.2%
- zolmitriptan: infrequent
- zolpidem: infrequent
- zonisamide: infrequent
- zopiclone: infrequent
- zuclopenthixol
|
Drugs with this indication
|
